Junju He

458 total citations
8 papers, 321 citations indexed

About

Junju He is a scholar working on Molecular Biology, Cancer Research and Immunology. According to data from OpenAlex, Junju He has authored 8 papers receiving a total of 321 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 5 papers in Cancer Research and 4 papers in Immunology. Recurrent topics in Junju He's work include Cancer-related molecular mechanisms research (4 papers), RNA modifications and cancer (3 papers) and interferon and immune responses (2 papers). Junju He is often cited by papers focused on Cancer-related molecular mechanisms research (4 papers), RNA modifications and cancer (3 papers) and interferon and immune responses (2 papers). Junju He collaborates with scholars based in China. Junju He's co-authors include Yuezhen Deng, Lunquan Sun, Yumei Duan, Liyu Liu, Jie Gao, Yun Mu, Yidi Guan, Xinxin Ren, Zhi Li and Shujun Fu and has published in prestigious journals such as Frontiers in Immunology, Cell Reports and Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease.

In The Last Decade

Junju He

8 papers receiving 319 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Junju He China	4	252	202	63	25	22	8	321
Nils Degrauwe Switzerland	5	342 1.4×	198 1.0×	59 0.9×	23 0.9×	24 1.1×	7	431
Yihang Guo China	13	347 1.4×	263 1.3×	53 0.8×	24 1.0×	46 2.1×	31	444
Yayun Cui China	11	345 1.4×	277 1.4×	80 1.3×	34 1.4×	47 2.1×	28	459
Luodan Zhao China	9	309 1.2×	182 0.9×	92 1.5×	20 0.8×	21 1.0×	11	371
Sheng‐Yan Huang China	11	245 1.0×	123 0.6×	53 0.8×	44 1.8×	58 2.6×	21	339
Shijia Yan China	7	250 1.0×	150 0.7×	66 1.0×	71 2.8×	36 1.6×	9	348
Xuetao Shi China	9	174 0.7×	147 0.7×	45 0.7×	19 0.8×	32 1.5×	13	292
Yunshi Zhong China	11	219 0.9×	152 0.8×	99 1.6×	20 0.8×	32 1.5×	24	331
Jihong Zhou China	11	259 1.0×	178 0.9×	42 0.7×	20 0.8×	29 1.3×	21	340

Countries citing papers authored by Junju He

Since Specialization

Citations

This map shows the geographic impact of Junju He's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Junju He with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Junju He more than expected).

Fields of papers citing papers by Junju He

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Junju He. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Junju He. The network helps show where Junju He may publish in the future.

Co-authorship network of co-authors of Junju He

This figure shows the co-authorship network connecting the top 25 collaborators of Junju He. A scholar is included among the top collaborators of Junju He based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Junju He. Junju He is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

8 of 8 papers shown

1.

Dan, Yock Young, Jing Li, Hao Zhong, et al.. (2025). Harnessing pseudogenes for lung cancer: A novel epigenetic target in diagnosis, prognosis and treatment. Critical Reviews in Oncology/Hematology. 208. 104645–104645. 1 indexed citations

2.

Chen, Jionghuang, Yifan Tong, Linghua Zhu, et al.. (2024). NSDHL promotes the degradation of sting in cholangiocarcinoma. Heliyon. 10(17). e37592–e37592. 1 indexed citations

3.

He, Junju, Qingqing Li, Chen Zhao, et al.. (2023). Advancement and Applications of Nanotherapy for Cancer Immune Microenvironment. Current Medical Science. 43(4). 631–646. 2 indexed citations

4.

Zhang, Haohan, Yi Yao, Jie Wu, et al.. (2022). Comprehensive Analysis Identifies and Validates the Tumor Microenvironment Subtypes to Predict Anti-Tumor Therapy Efficacy in Hepatocellular Carcinoma. Frontiers in Immunology. 13. 838374–838374. 2 indexed citations

5.

He, Junju, Zhi Li, Jie Gao, et al.. (2020). m6A Reader YTHDC2 Promotes Radiotherapy Resistance of Nasopharyngeal Carcinoma via Activating IGF1R/AKT/S6 Signaling Axis. Frontiers in Oncology. 10. 1166–1166. 66 indexed citations

6.

Li, Zhi, Junju He, Shujun Fu, et al.. (2019). Epstein–Barr virus noncoding RNAs from the extracellular vesicles of nasopharyngeal carcinoma (NPC) cells promote angiogenesis via TLR3/RIG-I-mediated VCAM-1 expression. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1865(6). 1201–1213. 38 indexed citations

7.

Li, Zhi, Junju He, Liyu Liu, et al.. (2019). Downregulation of Fat Mass and Obesity Associated (FTO) Promotes the Progression of Intrahepatic Cholangiocarcinoma. Frontiers in Oncology. 9. 369–369. 96 indexed citations

8.

Fu, Shujun, Zhi Li, Lanbo Xiao, et al.. (2019). Glutamine Synthetase Promotes Radiation Resistance via Facilitating Nucleotide Metabolism and Subsequent DNA Damage Repair. Cell Reports. 28(5). 1136–1143.e4. 115 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact